Devices for Inhaled Medications Market

List of Tables
Table 1. Devices for Inhaled Medications CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Devices for Inhaled Medications Market Trends
Table 3. Devices for Inhaled Medications Market Drivers
Table 4. Devices for Inhaled Medications Market Challenges
Table 5. Devices for Inhaled Medications Market Restraints
Table 6. Global Devices for Inhaled Medications Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Devices for Inhaled Medications Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Devices for Inhaled Medications Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Devices for Inhaled Medications Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Devices for Inhaled Medications Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Devices for Inhaled Medications Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Devices for Inhaled Medications Revenue Share by Manufacturer, 2017-2022
Table 13. Global Devices for Inhaled Medications Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Devices for Inhaled Medications Sales Share by Manufacturer, 2017-2022
Table 15. Global Devices for Inhaled Medications Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Devices for Inhaled Medications Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Devices for Inhaled Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Devices for Inhaled Medications as of 2021)
Table 18. Top Players of Devices for Inhaled Medications in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Devices for Inhaled Medications Product Type
Table 20. Date of International Manufacturers Enter into Devices for Inhaled Medications Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Devices for Inhaled Medications Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Devices for Inhaled Medications Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Devices for Inhaled Medications Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Devices for Inhaled Medications Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Devices for Inhaled Medications Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Devices for Inhaled Medications Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Devices for Inhaled Medications Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Devices for Inhaled Medications Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Devices for Inhaled Medications Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Devices for Inhaled Medications Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Devices for Inhaled Medications Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Devices for Inhaled Medications Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Devices for Inhaled Medications Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Devices for Inhaled Medications Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Devices for Inhaled Medications Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Devices for Inhaled Medications Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Devices for Inhaled Medications Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Devices for Inhaled Medications Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Devices for Inhaled Medications Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Devices for Inhaled Medications Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Consort Medical Corporation Information
Table 43. Consort Medical Description and Business Overview
Table 44. Consort Medical Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. Consort Medical Devices for Inhaled Medications Product
Table 46. Consort Medical Recent Development
Table 47. Inhalexper Corporation Information
Table 48. Inhalexper Description and Business Overview
Table 49. Inhalexper Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Inhalexper Product
Table 51. Inhalexper Recent Development
Table 52. Cambridge Consultants Corporation Information
Table 53. Cambridge Consultants Description and Business Overview
Table 54. Cambridge Consultants Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. Cambridge Consultants Product
Table 56. Cambridge Consultants Recent Development
Table 57. Hovione Corporation Information
Table 58. Hovione Description and Business Overview
Table 59. Hovione Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Hovione Product
Table 61. Hovione Recent Development
Table 62. Catalent, Inc Corporation Information
Table 63. Catalent, Inc Description and Business Overview
Table 64. Catalent, Inc Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Catalent, Inc Product
Table 66. Catalent, Inc Recent Development
Table 67. VertMarkets, Inc Corporation Information
Table 68. VertMarkets, Inc Description and Business Overview
Table 69. VertMarkets, Inc Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. VertMarkets, Inc Product
Table 71. VertMarkets, Inc Recent Development
Table 72. Qualicaps Corporation Information
Table 73. Qualicaps Description and Business Overview
Table 74. Qualicaps Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. Qualicaps Product
Table 76. Qualicaps Recent Development
Table 77. 3M Corporation Information
Table 78. 3M Description and Business Overview
Table 79. 3M Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. 3M Product
Table 81. 3M Recent Development
Table 82. Aerovance Corporation Information
Table 83. Aerovance Description and Business Overview
Table 84. Aerovance Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. Aerovance Product
Table 86. Aerovance Recent Development
Table 87. AstraZeneca Corporation Information
Table 88. AstraZeneca Description and Business Overview
Table 89. AstraZeneca Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 90. AstraZeneca Product
Table 91. AstraZeneca Recent Development
Table 92. Boehringer Ingelheim Corporation Information
Table 93. Boehringer Ingelheim Description and Business Overview
Table 94. Boehringer Ingelheim Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 95. Boehringer Ingelheim Product
Table 96. Boehringer Ingelheim Recent Development
Table 97. Chiesi Corporation Information
Table 98. Chiesi Description and Business Overview
Table 99. Chiesi Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 100. Chiesi Product
Table 101. Chiesi Recent Development
Table 102. Cipla Corporation Information
Table 103. Cipla Description and Business Overview
Table 104. Cipla Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 105. Cipla Product
Table 106. Cipla Recent Development
Table 107. Civitas/Alkermes Corporation Information
Table 108. Civitas/Alkermes Description and Business Overview
Table 109. Civitas/Alkermes Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 110. Civitas/Alkermes Product
Table 111. Civitas/Alkermes Recent Development
Table 112. GlaxoSmithKline Corporation Information
Table 113. GlaxoSmithKline Description and Business Overview
Table 114. GlaxoSmithKline Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 115. GlaxoSmithKline Product
Table 116. GlaxoSmithKline Recent Development
Table 117. Hovione Corporation Information
Table 118. Hovione Description and Business Overview
Table 119. Hovione Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 120. Hovione Product
Table 121. Hovione Recent Development
Table 122. Mannkind Corporation Information
Table 123. Mannkind Description and Business Overview
Table 124. Mannkind Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 125. Mannkind Product
Table 126. Mannkind Recent Development
Table 127. Mantecorp Corporation Information
Table 128. Mantecorp Description and Business Overview
Table 129. Mantecorp Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 130. Mantecorp Product
Table 131. Mantecorp Recent Development
Table 132. Meda Corporation Information
Table 133. Meda Description and Business Overview
Table 134. Meda Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 135. Meda Product
Table 136. Meda Recent Development
Table 137. MicroDose Therapeutx Corporation Information
Table 138. MicroDose Therapeutx Description and Business Overview
Table 139. MicroDose Therapeutx Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 140. MicroDose Therapeutx Product
Table 141. MicroDose Therapeutx Recent Development
Table 142. Novartis Corporation Information
Table 143. Novartis Description and Business Overview
Table 144. Novartis Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 145. Novartis Product
Table 146. Novartis Recent Development
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Devices for Inhaled Medications Customers List
Table 150. Devices for Inhaled Medications Distributors List
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Devices for Inhaled Medications Product Picture
Figure 2. Global Devices for Inhaled Medications Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Devices for Inhaled Medications Market Size 2017-2028 (US$ Million)
Figure 4. Global Devices for Inhaled Medications Sales 2017-2028 (K Units)
Figure 5. United States Devices for Inhaled Medications Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Devices for Inhaled Medications Market Size 2017-2028 (US$ Million)
Figure 7. United States Devices for Inhaled Medications Sales 2017-2028 (K Units)
Figure 8. United States Devices for Inhaled Medications Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Devices for Inhaled Medications Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Devices for Inhaled Medications Report Years Considered
Figure 11. Product Picture of Dry Powder Inhalers
Figure 12. Product Picture of Metered-Dose Inhalers
Figure 13. Product Picture of Nebulizers
Figure 14. Product Picture of Soft Mist Inhaler
Figure 15. Global Devices for Inhaled Medications Market Share by Type in 2022 & 2028
Figure 16. Global Devices for Inhaled Medications Sales in Value by Type (2017-2028) & (US$ Million)
Figure 17. Global Devices for Inhaled Medications Sales Market Share in Value by Type (2017-2028)
Figure 18. Global Devices for Inhaled Medications Sales by Type (2017-2028) & (K Units)
Figure 19. Global Devices for Inhaled Medications Sales Market Share in Volume by Type (2017-2028)
Figure 20. Global Devices for Inhaled Medications Price by Type (2017-2028) & (USD/Unit)
Figure 21. United States Devices for Inhaled Medications Market Share by Type in 2022 & 2028
Figure 22. United States Devices for Inhaled Medications Sales in Value by Type (2017-2028) & (US$ Million)
Figure 23. United States Devices for Inhaled Medications Sales Market Share in Value by Type (2017-2028)
Figure 24. United States Devices for Inhaled Medications Sales by Type (2017-2028) & (K Units)
Figure 25. United States Devices for Inhaled Medications Sales Market Share in Volume by Type (2017-2028)
Figure 26. United States Devices for Inhaled Medications Price by Type (2017-2028) & (USD/Unit)
Figure 27. Product Picture of Clinic
Figure 28. Product Picture of Hospital
Figure 29. Product Picture of Household
Figure 30. Global Devices for Inhaled Medications Market Share by Application in 2022 & 2028
Figure 31. Global Devices for Inhaled Medications Sales in Value by Application (2017-2028) & (US$ Million)
Figure 32. Global Devices for Inhaled Medications Sales Market Share in Value by Application (2017-2028)
Figure 33. Global Devices for Inhaled Medications Sales by Application (2017-2028) & (K Units)
Figure 34. Global Devices for Inhaled Medications Sales Market Share in Volume by Application (2017-2028)
Figure 35. Global Devices for Inhaled Medications Price by Application (2017-2028) & (USD/Unit)
Figure 36. United States Devices for Inhaled Medications Market Share by Application in 2022 & 2028
Figure 37. United States Devices for Inhaled Medications Sales in Value by Application (2017-2028) & (US$ Million)
Figure 38. United States Devices for Inhaled Medications Sales Market Share in Value by Application (2017-2028)
Figure 39. United States Devices for Inhaled Medications Sales by Application (2017-2028) & (K Units)
Figure 40. United States Devices for Inhaled Medications Sales Market Share in Volume by Application (2017-2028)
Figure 41. United States Devices for Inhaled Medications Price by Application (2017-2028) & (USD/Unit)
Figure 42. North America Devices for Inhaled Medications Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 43. North America Devices for Inhaled Medications Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 44. U.S. Devices for Inhaled Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Canada Devices for Inhaled Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Europe Devices for Inhaled Medications Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 47. Europe Devices for Inhaled Medications Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 48. Germany Devices for Inhaled Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. France Devices for Inhaled Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. U.K. Devices for Inhaled Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Italy Devices for Inhaled Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Russia Devices for Inhaled Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Asia-Pacific Devices for Inhaled Medications Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 54. Asia-Pacific Devices for Inhaled Medications Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 55. China Devices for Inhaled Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Japan Devices for Inhaled Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. South Korea Devices for Inhaled Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. India Devices for Inhaled Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Australia Devices for Inhaled Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Taiwan Devices for Inhaled Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Indonesia Devices for Inhaled Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Thailand Devices for Inhaled Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Malaysia Devices for Inhaled Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Philippines Devices for Inhaled Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Latin America Devices for Inhaled Medications Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 66. Latin America Devices for Inhaled Medications Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 67. Mexico Devices for Inhaled Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Brazil Devices for Inhaled Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Argentina Devices for Inhaled Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Middle East & Africa Devices for Inhaled Medications Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 71. Middle East & Africa Devices for Inhaled Medications Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 72. Turkey Devices for Inhaled Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Saudi Arabia Devices for Inhaled Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. U.A.E Devices for Inhaled Medications Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. Devices for Inhaled Medications Value Chain
Figure 76. Devices for Inhaled Medications Production Process
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed